Cargando…

miR-29a Modulates Neuronal Differentiation through Targeting REST in Mesenchymal Stem Cells

OBJECTIVE: To investigate the modulation of microRNAs (miRNAs) upon the neuronal differentiation of mesenchymal stem cells (MSCs) through targeting RE-1 Silencing Factor (REST), a mature neuronal gene suppressor in neuronal and un-neuronal cells. METHODS: Rat bone marrow derived–MSCs were induced in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Ping, Sun, Shiling, Li, Bo, Huang, Chuntian, Xu, Yan, Han, Xuefei, Xing, Ying, Yan, Wenhai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026383/ https://www.ncbi.nlm.nih.gov/pubmed/24841827 http://dx.doi.org/10.1371/journal.pone.0097684

Ejemplares similares

miR-29a activates Hes1 by targeting Nfia in esophageal carcinoma cell line TE-1
por: LIU, CHANG, et al.
Publicado: (2015)

Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia
por: Xu, Ling, et al.
Publicado: (2014)

Hepatic miR-29ab1 expression modulates chronic hepatic injury
por: Kogure, Takayuki, et al.
Publicado: (2012)

Association of H-Type Hypertension with miR-21, miR-29, and miR-199 in Kazahks of Xinjiang, China
por: He, Xin, et al.
Publicado: (2022)

Mesenchymal stromal cells facilitate resolution of pulmonary fibrosis by miR-29c and miR-129 intercellular transfer
por: Nataliya, Basalova, et al.
Publicado: (2023)

Neuronal miR-29a protects from obesity in adult mice
por: Ma, Yuan, et al.
Publicado: (2022)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Longer Work/Rest Intervals During High-Intensity Interval Training (HIIT) Lead to Elevated Levels of miR-222 and miR-29c
por: Schmitz, Boris, et al.
Publicado: (2018)

miR-29b contributes to multiple types of muscle atrophy
por: Li, Jin, et al.
Publicado: (2017)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

The role of miR‐29 family in disease
por: Horita, Masahiro, et al.
Publicado: (2021)

miR-29b and miR-29c Are Involved in Toll-Like Receptor Control of Glucocorticoid-Induced Apoptosis in Human Plasmacytoid Dendritic Cells
por: Hong, Yongfeng, et al.
Publicado: (2013)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
por: Bayat, Parisa, et al.
Publicado: (2022)

LncRNA‐ATB regulates epithelial‐mesenchymal transition progression in pulmonary fibrosis via sponging miR‐29b‐2‐5p and miR‐34c‐3p
por: Xu, Qi, et al.
Publicado: (2021)

Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer
por: Zhao, Xin, et al.
Publicado: (2018)

The role of miR-29b in cancer: regulation, function, and signaling
por: Yan, Bin, et al.
Publicado: (2015)

Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice
por: Roshan, Reema, et al.
Publicado: (2014)

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus
por: Hezova, Renata, et al.
Publicado: (2015)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

MiR-29/Hsp47 in ECM network
por: Xu, Ren
Publicado: (2015)

A Systematic Review of miR-29 in Cancer
por: Kwon, Jason J., et al.
Publicado: (2018)

The Role of miR-29s in Human Cancers—An Update
por: Nguyen, Thuy T. P., et al.
Publicado: (2022)

REST, regulated by RA through miR-29a and the proteasome pathway, plays a crucial role in RPC proliferation and differentiation
por: Wang, Yuyao, et al.
Publicado: (2018)

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia
por: Ngankeu, Apollinaire, et al.
Publicado: (2017)

Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
por: Tao, Wenhua, et al.
Publicado: (2016)

The Effect of Advanced Motherhood on Newborn Offspring's Hippocampal Neural Stem Cell Proliferation
por: Li, Bo, et al.
Publicado: (2016)

miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells
por: Okamoto, Kinya, et al.
Publicado: (2013)

Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance
por: Zhu, Chuanan, et al.
Publicado: (2018)

Plasma levels of miR‐29b and miR‐200b in type 2 diabetic retinopathy
por: Dantas da Costa e Silva, Maria Enoia, et al.
Publicado: (2018)

miR-210 enhances mesenchymal stem cell-modulated neural precursor cell migration
por: Wang, Faxiang, et al.
Publicado: (2020)

Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer
por: Zhu, Wangyu, et al.
Publicado: (2014)

Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients
por: Raeisi, Farzaneh, et al.
Publicado: (2020)

MiR-29a: a potential therapeutic target and promising biomarker in tumors
por: Wang, Jin-yan, et al.
Publicado: (2018)

The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization
por: Keikha, Reza, et al.
Publicado: (2021)

Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients
por: Bache, Matthias, et al.
Publicado: (2023)

ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer
por: Duhachek-Muggy, Sara, et al.
Publicado: (2015)

Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer
por: Zhang, Qian, et al.
Publicado: (2023)

MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC
por: Zou, Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mesdmoin4d3snetue6l8grfp0s